Related Experiment Videos
Psychotherapeutic considerations in pharmacological trials
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06511, USA.
Alcoholism, Clinical and Experimental Research
|October 1, 1996
Summary
Psychotherapy significantly improves the evaluation of medications for alcohol abuse treatment. Integrating psychosocial therapy enhances patient retention and medication adherence, reinforcing pharmacological effects.
Area of Science:
- Addiction medicine
- Psychiatry
- Clinical psychology
Background:
- Pharmacological agents are crucial for treating alcohol abuse and dependence.
- Psychotherapy has shown promise in supporting treatment outcomes.
- Evaluating medication efficacy requires robust study designs.
Purpose of the Study:
- To highlight the beneficial role of psychotherapy in clinical trials for alcohol use disorders.
- To emphasize how psychosocial interventions improve the assessment of pharmacotherapy.
Main Methods:
- Review of recent studies on combined psychotherapy and pharmacotherapy for alcohol use disorders.
- Analysis of the impact of psychosocial therapy on patient retention and medication compliance in clinical trials.
Main Results:
- Psychosocial therapy enhances patient retention in clinical trials.
- It improves medication compliance for pharmacological agents.
- New skills acquired through therapy reinforce medication effects.
Conclusions:
- Psychosocial therapy is essential for accurately evaluating the efficacy of pharmacological agents in alcohol abuse and dependence treatment.
- Integrating psychotherapy into study designs optimizes the assessment of pharmacotherapy effectiveness.
- This approach leads to a more thorough understanding of treatment outcomes.